A carregar...
Sorafenib for the treatment of hepatocellular carcinoma
The multikinase inhibitor sorafenib, which inhibits targets related to tumor cell proliferation and angiogenesis, was the first systemic agent to demonstrate a significant improvement in the overall survival for patients with advanced hepatocellular carcinoma (HCC) in two large randomized controlled...
Na minha lista:
| Publicado no: | Hepat Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6095169/ https://ncbi.nlm.nih.gov/pubmed/30190954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep.13.20 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|